David R. Bauer
Lawyers
Filters
Novo Nordisk acquisition of Neotope Neuroscience
We advised Novo Nordisk on the acquisition
Aligos Therapeutics $83.6 million follow-on offering
We advised the underwriters on the stock offering
Integral Ad Science Holding $270 million IPO
We advised the underwriters on the IPO and Nasdaq listing
GH Research $184 million IPO
We advised GH Research on the IPO and Nasdaq Listing
Theravance Biopharma $100.5 million follow-on offering
We advised the underwriters on the equity offering
ATAI Life Sciences $258.8 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Century Therapeutics $242.7 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Cyteir Therapeutics $133.2 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Molecular Partners $64 million IPO
We advised the joint book-running managers and underwriters on the IPO and Nasdaq listing
RAPT Therapeutics $143.7 million follow-on offering
We advised the joint book-running managers on the SEC-registered equity offering